Mengis Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McCormick & Company Non-Voting
MKC
|
+$3.46M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$2.56M |
| 3 |
Marvell Technology
MRVL
|
+$1.94M |
| 4 |
Microsoft
MSFT
|
+$1.79M |
| 5 |
PACCAR
PCAR
|
+$1.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.21M |
| 2 |
ATI
ATI
|
+$832K |
| 3 |
Costco
COST
|
+$406K |
| 4 |
Verizon
VZ
|
+$313K |
| 5 |
Bristol-Myers Squibb
BMY
|
+$298K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.34% |
| 2 | Industrials | 16.46% |
| 3 | Healthcare | 13.71% |
| 4 | Consumer Staples | 8.96% |
| 5 | Financials | 7.43% |
Similar funds
Mengis Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Mengis Capital Management held 217 positions worth $566M, up 11% from $509M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Mengis Capital Management deployed $33.6M of net new capital in Q4 2025, opening 10 new positions and adding to 89 existing holdings. Its largest new stake was Qnity Electronics Inc: 11,244 shares worth $918K.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was DuPont de Nemours, an estimated $1.21M trimmed.
- Mengis Capital Management's largest Q4 2025 buy was Qnity Electronics Inc: 11,244 shares worth $918K.
- Mengis Capital Management added most to McCormick & Company Non-Voting in Q4 2025, an estimated $3.46M increase.
- Mengis Capital Management's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $1.21M.
- Mengis Capital Management fully exited Kellanova in Q4 2025, selling an estimated $215K.
- Mengis Capital Management's ten largest holdings make up 32% of its $566M portfolio in Q4 2025.
- Mengis Capital Management opened 10 new positions and closed 8 in Q4 2025.
- Mengis Capital Management's portfolio value rose 11% quarter-over-quarter to $566M.
Based on Mengis Capital Management's 13F filing for Q4 2025, filed 5 Mar 2026.